Long‐term follow‐up of a prospective, double‐blind, placebo‐controlled randomized trial of clodronate in multiple myeloma
Oral clodronate (1600 mg/d) has been shown to significantly reduce the incidence of skeletal complications in multiple myeloma. Preliminary analysis of a double‐blind placebo‐controlled trial of this treatment indicated that clodronate might prolong survival in patients without vertebral fractures a...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | engelska |
| Publicerad: |
2001
|
| Länkar: | https://doi.org/10.1046/j.1365-2141.2001.02851.x https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2001.02851.x |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|